Processes for the preparation of substituted quinazolines

Number of patents in Portfolio can not be more than 2000

United States of America

PATENT NO 9163006
SERIAL NO

14060123

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present disclosure provides compounds for modulating receptor kinase activity, particularly ephrin and EGFR, and methods of treating diseases mediated by receptor kinase activity utilizing the compounds and pharmaceutical compositions thereof. The compounds are generally of formula (I):

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • SYMPHONY EVOLUTION, INC.

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Anand, Neel K Burlingame, US 25 68
Blazey, Charles M San Francisco, US 21 293
Bussenius, Joerg Foster City, US 23 354
Costanzo, Simona Los Altos, US 20 189
Kennedy, Abigail R San Leandro, US 19 330
Peto, Csaba J Alameda, US 28 366
Rice, Kenneth D Mill Valley, US 33 558
Tsang, Tsze H El Cerrito, US 31 483

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Apr 20, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00